207 related articles for article (PubMed ID: 18386236)
1. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients.
Akkiprik M; Celikel CA; Düşünceli F; Sönmez O; Güllüoğlu BM; Sav A; Ozer A
Turk J Gastroenterol; 2008 Mar; 19(1):22-7. PubMed ID: 18386236
[TBL] [Abstract][Full Text] [Related]
2. Relationship between expression of ras p21 oncoprotein and mutation status of the K-ras gene in sporadic colorectal cancer patients in Tunisia.
Sammoud S; Khiari M; Semeh A; Amine L; Ines C; Amira A; Lilia K; Taher K; Sabeh M; Saadia B
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):146-52. PubMed ID: 21768877
[TBL] [Abstract][Full Text] [Related]
3. [Molecular oncological study on DNA ploidy, Ki-ras point mutation, and p21 expression in colorectal cancer].
Yamazaki K; Sato K; Hirata S; Ikeda K; Kubo Y; Matsui H; Ogawa K
Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):242-7. PubMed ID: 8196591
[TBL] [Abstract][Full Text] [Related]
4. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
5. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
6. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
7. K-ras gene point mutations and p21ras immunostaining in human ovarian tumors.
Semczuk A; Postawski K; Przadka D; Rozynska K; Wrobel A; Korobowicz E
Eur J Gynaecol Oncol; 2004; 25(4):484-8. PubMed ID: 15285310
[TBL] [Abstract][Full Text] [Related]
8. [Mutation analysis of K-ras protooncogene in colorectal adenocarcinomas and polyps in Russian patients].
Amosenko FA; Korchagina EL; Matveeva TI; Vaganov IuE; Vlasov SB; Poltavets NV; Veselov VV; Gar'kavtseva RF; Poliakov AV
Genetika; 2010 May; 46(5):700-8. PubMed ID: 20583607
[TBL] [Abstract][Full Text] [Related]
9. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
10. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
11. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
13. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
14. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
[TBL] [Abstract][Full Text] [Related]
15. Association of K-ras mutations with liver metastases from colorectal carcinoma.
Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M
Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200
[TBL] [Abstract][Full Text] [Related]
16. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
[TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
[TBL] [Abstract][Full Text] [Related]
18. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
19. Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan.
Wu CM; Tang R; Wang JY; Changchien CR; Hsieh LL
Cancer Genet Cytogenet; 2005 Apr; 158(1):55-60. PubMed ID: 15771905
[TBL] [Abstract][Full Text] [Related]
20. High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients.
Wang JY; Hsieh JS; Chen FM; Yeh CS; Alexandersen K; Huang TJ; Chen Dc; Lin SR
Int J Cancer; 2003 Nov; 107(3):387-93. PubMed ID: 14506738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]